Lumos Pharma’s oral treatment for moderate pediatric growth hormone deficiency has failed to match up to Novo Nordisk’s injected drug Norditropin at the interim analysis of a phase 2 trial.

Children with growth hormone deficiency (GHD) showed abnormal craniofacial morphology with reduced mandibular dimensions, according to a recent review of published literature. It is already known ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

Business Wire September 24, 2018 5:25 AM AUSTIN, Texas– (BUSINESS WIRE)–September 24, 2018– ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

Growth hormone use is exploding among pre-teens with wealthy parents seeking out a fast growth solution for kids who don't measure up to their peers. Getty Images/iStockphoto There’s no expense ...

Lumos Pharma Inc.’s novel approach with LUM-201 in pediatric growth hormone deficiency paid off in top-line results, and the company is laying the groundwork for a phase III study next year. Pisit ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally ...